Want to see TNYA full AI Analyst Report?
Tenaya Therapeutics (TNYA) Income Statement
Tenaya Therapeutics Income Statement
Last quarter (Q2 2026), Tenaya Therapeutics's total revenue was $1.11M. In Q2, Tenaya Therapeutics's net income was $-43.39M. See Tenaya Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -8.44M | $ -8.47M | $ -8.69M | $ -8.71M | $ -4.03M | |
| $ 84.89M | $ 107.48M | $ 122.51M | $ 116.91M | $ 68.78M | |
| Depreciation and Amortization | $ 8.44M | $ 8.47M | $ 8.69M | $ 6.47M | $ 2.96M |
| $ -82.16M | $ -102.66M | $ -115.40M | $ -117.20M | $ -69.76M | |
| $ -93.33M | $ -115.95M | $ -131.19M | $ -125.62M | $ -72.81M | |
| $ 2.73M | $ 4.82M | $ 7.11M | $ 1.96M | $ 85.00K | |
| $ -90.60M | $ -111.13M | $ -124.08M | $ -123.67M | $ -72.72M | |
| $ -90.60M | $ -111.13M | $ -124.08M | $ -123.67M | $ -72.72M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.59 | $ -1.31 | $ -1.68 | $ -2.76 | $ -1.69 |
| Diluted EPS | $ -0.59 | $ -1.31 | $ -1.68 | $ -2.76 | $ -1.69 |
| Weighted Average Shares Outstanding | 152.97M | 84.82M | 73.79M | 44.82M | 41.29M |
| Weighted Average Shares Outstanding (Diluted) | 152.97M | 84.82M | 73.79M | 44.82M | 41.29M |
Currency in USD
